Covered recipient · General Payments record
LISA JOHNSON KIRK
Allopathic & Osteopathic Physicians Family Medicine
General Payments · PY2018–2024
$3,074.11
- Reported across 190 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $308.11 | 18 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Novo Nordisk AS | $111.99 | 7 |
| Lilly USA, LLC | $102.80 | 6 |
| Astellas Pharma US Inc | $37.54 | 2 |
| Merck Sharp & Dohme Corporation | $23.04 | 1 |
| Acella Pharmaceuticals, LLC | $19.50 | 1 |
| ABBVIE INC. | $13.24 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (18)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $13.24 | 02/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104080360 | CMS |
| Acella Pharmaceuticals, LLC | $19.50 | 10/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1126636068 | CMS |
| Astellas Pharma US Inc | $19.32 | 01/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139309062 | CMS |
| Astellas Pharma US Inc | $18.22 | 05/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139361555 | CMS |
| Lilly USA, LLC | $16.99 | 01/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135135474 | CMS |
| Lilly USA, LLC | $20.25 | 02/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135145157 | CMS |
| Lilly USA, LLC | $17.59 | 06/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135091703 | CMS |
| Lilly USA, LLC | $18.61 | 07/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135145159 | CMS |
| Lilly USA, LLC | $13.32 | 08/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135154694 | CMS |
| Lilly USA, LLC | $16.04 | 10/31/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135156509 | CMS |
| Merck Sharp & Dohme LLC | $23.04 | 06/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1141598556 | CMS |
| Novo Nordisk Inc | $17.31 | 01/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1097672518 | CMS |
| Novo Nordisk Inc | $17.64 | 03/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1096589099 | CMS |
| Novo Nordisk Inc | $16.41 | 03/28/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1096587439 | CMS |
| Novo Nordisk Inc | $13.61 | 05/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1097673838 | CMS |
| Novo Nordisk Inc | $14.48 | 08/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1097504538 | CMS |
| Novo Nordisk Inc | $16.51 | 09/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1097106550 | CMS |
| Novo Nordisk Inc | $16.03 | 11/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1096812169 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2019, 2020, 2021, 2022, 2023, 2024
- Source files
- Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.